Kolexia
Champion Laurence Médecine nucléaire
Champion Laurence
Médecine nucléaire
Institut Curie
Saint-Cloud, France
80 Activités
275 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du poumon Récidive tumorale locale Carcinomes Tumeurs de la tête et du cou Mélanome Métastase tumorale Carcinome pulmonaire à petites cellules COVID-19

Collaborateurs

Voir plus
Seban Romain-David
Seban Romain-David
Institut Curie, Saint-Cloud, France
Alberini Jean-Louis
Alberini Jean-Louis
Hôpital François Mitterrand, Dijon, France
Edeline Veronique
Edeline Veronique
Hôpital Pitie Salpetriere, Paris, France
Richard Capucine
Richard Capucine
Institut Curie, Saint-Cloud, France

Industries

Voir plus
Advanced Accelerator Applications
2 collaboration(s)
Dernière en 2022
ADVANCED ACCELERATOR APPLICATIONS
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.
Cancer treatment reviews   13 janvier 2024
Clinical Utility of Pre-Therapeutic 18FFDG PET/CT Imaging for Predicting Outcomes in Breast Cancer.
Journal of clinical medicine   24 août 2023
18FFDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
European journal of nuclear medicine and molecular imaging   22 août 2023
Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
International journal of radiation biology   21 août 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.
Journal of clinical medicine   25 juillet 2023
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Nature communications   22 juin 2023
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]   31 mai 2023
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   25 mai 2023
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.
Cancers   10 avril 2023
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Journal of neurosurgery   07 avril 2023